Companies implementing Health Economics Outcomes Research (HEOR)

HEOR blends economic and outcomes analyses with traditional clinical data—such as efficacy, safety, and quality—to assist decision‑makers in determining patient access to drugs and services.

1,925

companies

List of companies that implement Health Economics Outcomes Research (HEOR)

CompanyCountryIndustryEmployeesRevenueTechnologies
Country flag

United States

Biotechnology Research

6.2k

$7.6B

Health Economics Outcomes Research (HEOR)

Country flag

United States

Pharmaceutical Manufacturing

39k

$46B

Health Economics Outcomes Research (HEOR)

Country flag

United States

Pharmaceutical Manufacturing

62k

$26B

Health Economics Outcomes Research (HEOR)

Country flag

Switzerland

Pharmaceutical Manufacturing

102k

$51B

Health Economics Outcomes Research (HEOR)

Country flag

France

Pharmaceutical Manufacturing

92k

$46B

Health Economics Outcomes Research (HEOR)

Country flag

Switzerland

Research Services

130k

$44B

Health Economics Outcomes Research (HEOR)

Country flag

United States

Hospitals and Health Care

81k

$14B

Health Economics Outcomes Research (HEOR)

Country flag

Germany

Pharmaceutical Manufacturing

53k

$26B

Health Economics Outcomes Research (HEOR)

Country flag

United Kingdom

Pharmaceutical Manufacturing

79k

Health Economics Outcomes Research (HEOR)

Country flag

United States

Pharmaceutical Manufacturing

103k

$100B

Health Economics Outcomes Research (HEOR)

Showing top companies out of 1,925 that implement Health Economics Outcomes Research (HEOR). Get the full list on TheirStack.

Frequently asked questions